“Determination of Sensitivity and Specificity of Straight Leg Raise Test Via Transforaminal Nerve Root Block

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Lumbosacral Radicular Pain; Lumbar Radiculopathy; Straight Leg Raise Sponsors: Marmara University Recruiting Conditions: Lumbosacral Radicular Pain; Lumbar Radiculopathy; Straight Leg Raise Sponsors: Marmara University...

IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Recurrent Prostate Cancer; Prostate Cancer Interventions: Drug: N-803; Drug: ETBX-71 Vaccine; Radiation: 18F-DCFPyL Sponsors: National Cancer Institute (NCI) Not yet recruiting Conditions: Recurrent Prostate Cancer; Prostate Cancer Interventions: Drug:...

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Type 2 Diabetes; Type 2 Diabetes (T2DM) Interventions: Device: Eroxon®; Drug: tadalafil Sponsors: University of Miami; Sexual Medicine Society of North America Inc. Not yet recruiting Conditions: Type 2 Diabetes; Type 2 Diabetes (T2DM) Interventions:...

REstoration of SYNChronous Cardiac Function Due to Physiologic cArdiac Pacing Modalities With Clinical Endpoints

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Heart Failure – NYHA II – IV; Left Bundle Branch Area Pacing; Left Bundle Branch Block; Intraventricular Conduction Delay; Resynchronization Therapy Interventions: Device: Physiologic cardiac resynchronization using conduction system pacing...

A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression

by palligoelme@gmail.com | Jul 10, 2026 | Clinical Trials

​ Conditions: Solid Tumor (Phase I); RAS Mutation; CEACAM5 Interventions: Drug: Intravenous AN4035; Drug: Intravenous AN4035 followed by intravenous EGFR Inhibitor. Sponsors: Adlai Nortye Biopharma Co., Ltd. Not yet recruiting Conditions: Solid Tumor (Phase I); RAS...